Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective study
Brachytherapy · 2026
DOI: 10.1016/j.brachy.2025.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brachytherapy, 2026. Verfasst von Selnur Özkurt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Brachytherapy, Genital Neoplasms, Female. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Managing locally recurrent gynecologic cancer with pelvic wall invasion, particularly after prior pelvic radiotherapy, presents a significant clinical challenge. Combined operative and radiotherapeutic treatment (CORT) is a potential curative approach. This study aims to evaluate the effectiveness and morbidity of this technique in this patient population as implemented within a single institution. METHODS AND MATERIALS: A comprehensive, retrospective analysis was conducted on patients treated with CORT for recurrent gynecologic cancer with pelvic wall invasion after prior pelvic radiotherapy at the University Hospitals of Leuven between January 2000 and December 2023. RESULTS: A total of 21 patients were eligible for analysis. All patients underwent open surgical macroscopic tumor resection with intraoperative implantation of brachytherapy guiding tubes. The average radiation dose to 90% of the treatment volume (D90) was 45.6 Gy EQD2 (range 16.0 to 66.2 Gy). The median follow-up period was 37.8 months (range 3-230 months). Local control at 2 and 5 years was 87,4% and 77,8%; overall-survival at 2 and 5 years was 57,1% and 52,4%, respectively. Seventeen of the 21 patients experienced some form of adverse event, with 15 patients needing surgical re-intervention. CONCLUSIONS: Our retrospective analysis demonstrates high local control and favorable overall-survival outcomes in patients with recurrent gynecologic cancer involving the pelvic wall. However, the treatment is associated with a substantial risk of severe adverse events. Given the complexity and potential morbidity of this approach, CORT should be performed in specialized centers with experience in managing such cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
- Department of Radiation Oncology, University Hospital Ghent, Gent, Belgium.
- Department of Obstetrics and Gynecology, Division of Gynecological Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
- Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. Electronic address: melissa.christiaens@uzleuven.be.
Zitieren
APA
Özkurt, S., Oldenburger, E., Tambeur, V., Delombaerde, L., Baert, T., Vergote, I., Van Gorp, T., Van Nieuwenhuysen, E., De Brabandere, M., Nulens, A., Janssen, H., Van Limbergen, E., & Christiaens, M. (2026). Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective study. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.09.003
Vancouver
Özkurt S, Oldenburger E, Tambeur V, Delombaerde L, Baert T, Vergote I, et al. Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective study. Brachytherapy. 2026. doi:10.1016/j.brachy.2025.09.003
BibTeX
@article{zkurt2026,
author = {Özkurt, Selnur and Oldenburger, Eva and Tambeur, Vincent and Delombaerde, Laurence and Baert, Thaïs and Vergote, Ignace and Van Gorp, Toon and Van Nieuwenhuysen, Els and De Brabandere, Marisol and Nulens, An and Janssen, Hilde and Van Limbergen, Erik and Christiaens, Melissa},
title = {Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective study},
journal = {Brachytherapy},
year = {2026},
doi = {10.1016/j.brachy.2025.09.003}
}
EUVIMED